AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in ABBV / AbbVie Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of AbbVie Inc. (US:ABBV) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 911,288 shares of AbbVie Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 0 -100.00 0
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 911,288 -826 -0.09 169,153 -11.49 0.4859
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 912,114 -59,779 -6.15 191,106 10.65 0.6277
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 971,893 125,568 14.84 172,705 3.33 0.5246
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 846,325 -197,492 -18.92 167,132 -6.65 0.4949
2025-02-25 2024-06-30 13F/A-1 ABBVIE COM 00287Y109 1,043,817 -63,943 -5.77 179,035 -11.25 0.5326
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 1,043,817 -63,943 179,035 0.5326
2024-05-15 2024-03-31 13F ABBVIE COM 00287Y109 1,107,760 40,675 3.81 201,723 21.99 0.6047
2024-07-16 2023-12-31 13F/A-1 ABBVIE COM 00287Y109 1,067,085 -131,449 -10.97 165,366 -7.44 0.5332
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 1,067,085 -131,449 165,366 0.3239
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 1,198,534 298,125 33.11 178,653 47.27 0.6279
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 900,409 197,609 28.12 121,312 8.31 0.4031
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 702,800 225,151 47.14 112,005 45.10 0.3853
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 477,649 27,523 6.11 77,193 27.78 0.2785
2023-02-14 2022-09-30 13F/A-1 AbbVie COM 00287Y109 450,126 -98,834 -18.00 60,411 -28.15 0.2377
2022-11-14 2022-09-30 13F AbbVie COM 00287Y109 450,126 -98,834 60,412 0.2377
2023-02-14 2022-06-30 13F/A-1 AbbVie COM 00287Y109 548,960 -182,575 -24.96 84,079 -29.10 0.3116
2022-08-15 2022-06-30 13F AbbVie COM 00287Y109 548,960 -182,575 84,079 0.3116
2023-02-14 2022-03-31 13F/A-1 AbbVie COM 00287Y109 731,535 -296,812 -28.86 118,589 -14.83 0.3370
2022-05-13 2022-03-31 13F AbbVie COM 00287Y109 731,535 -296,812 118,589 0.3371
2022-02-14 2021-12-31 13F AbbVie COM 00287Y109 1,028,347 -277,917 -21.28 139,239 -1.18 0.3559
2021-11-15 2021-09-30 13F AbbVie COM 00287Y109 1,306,264 300,804 29.92 140,906 24.41 0.3954
2021-08-13 2021-06-30 13F/A-1 AbbVie COM 00287Y109 1,005,460 190,744 23.41 113,255 28.45 0.3193
2021-08-13 2021-06-30 13F AbbVie COM 00287Y109 1,005,460 190,744 113,255 0.1912
2021-05-14 2021-03-31 13F AbbVie COM 00287Y109 814,716 44,223 5.74 88,168 6.80 0.2685
2021-02-12 2020-12-31 13F AbbVie COM 00287Y109 770,493 43,257 5.95 82,558 29.61 0.2591
2021-02-11 2020-09-30 13F/A-1 AbbVie COM 00287Y109 727,236 -68,842 -8.65 63,698 -18.50 0.2302
2020-11-13 2020-09-30 13F AbbVie COM 00287Y109 727,236 -68,842 63,698 127,151.3176
2021-02-12 2020-06-30 13F/A-1 ABBVIE COM 00287Y109 796,078 297,331 59.62 78,160 105.68 0.3079
2020-08-14 2020-06-30 13F ABBVIE COM 00287Y109 796,078 297,331 78,160 308,235.3659
2021-02-12 2020-03-31 13F/A-2 ABBVIE COM 00287Y109 498,747 133,800 36.66 38,001 17.61 0.1899
2020-06-15 2020-03-31 13F/A-1 ABBVIE COM 00287Y109 498,747 0 38,001 0.1901
2020-05-15 2020-03-31 13F ABBVIE COM 00287Y109 498,747 133,800 38,001 105,681.4346
2021-02-12 2019-12-31 13F/A-1 ABBVIE COM 00287Y109 364,947 -281,663 -43.56 32,312 -34.00 0.1314
2020-02-18 2019-12-31 13F ABBVIE COM 00287Y109 364,947 -281,663 32,312 131,563.4161
2021-02-12 2019-09-30 13F/A-1 ABBVIE COM 00287Y109 646,610 -48,497 -6.98 48,961 -3.14 0.1948
2019-11-14 2019-09-30 13F ABBVIE COM 00287Y109 646,610 -48,497 48,961 195,112.7020
2021-02-12 2019-06-30 13F/A-1 ABBVIE COM 00287Y109 695,107 -33,030 -4.54 50,549 -13.86 0.1973
2019-08-13 2019-06-30 13F ABBVIE COM 00287Y109 695,107 -33,030 50,549 198,231.9167
2019-05-14 2019-03-31 13F ABBVIE COM 00287Y109 728,137 -56,675 -7.22 58,682 -18.89 0.2293
2019-02-13 2018-12-31 13F ABBVIE COM 00287Y109 784,812 -37,199 -4.53 72,352 -6.94 0.3154
2018-11-08 2018-09-30 13F ABBVIE COM 00287Y109 822,011 2,162 0.26 77,746 2.35 0.2852
2018-08-13 2018-06-30 13F ABBVIE COM 00287Y109 819,849 -832,321 -50.38 75,959 -51.43 0.2911
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 1,652,170 -399,615 -19.48 156,377 -21.19 0.6241
2018-02-13 2017-12-31 13F ABBVIE COM 00287Y109 2,051,785 234,158 12.88 198,428 22.85 0.7792
2017-12-01 2017-09-30 13F/A-1 ABBVIE COM 00287Y109 1,817,627 -73,778 -3.90 161,515 17.77 0.6958
2017-11-13 2017-09-30 13F ABBVIE COM 00287Y109 1,817,627 -73,778 161,515
2017-08-10 2017-06-30 13F ABBVIE COM 00287Y109 1,891,405 -668,302 -26.11 137,146 -17.77 0.6226
2017-05-11 2017-03-31 13F ABBVIE COM 00287Y109 2,559,707 -213,275 -7.69 166,791 -3.95 0.7530
2017-02-13 2016-12-31 13F ABBVIE COM 00287Y109 2,772,982 -177,323 -6.01 173,644 -6.68 0.8148
2016-11-10 2016-09-30 13F ABBVIE COM 00287Y109 2,950,305 15,394 0.52 186,076 2.41 0.8174
2016-08-11 2016-06-30 13F ABBVIE COM 00287Y109 2,934,911 -126,273 -4.12 181,700 3.91 0.8095
2016-05-13 2016-03-31 13F ABBVIE COM 00287Y109 3,061,184 1,304,557 74.26 174,855 68.03 0.7844
2016-02-12 2015-12-31 13F ABBVIE COM 00287Y109 1,756,627 205,501 13.25 104,062 23.30 0.4547
2015-11-13 2015-09-30 13F ABBVIE COM 00287Y109 1,551,126 -19,707 -1.25 84,397 -20.04 0.3460
2015-08-13 2015-06-30 13F ABBVIE COM 00287Y109 1,570,833 171,600 12.26 105,544 28.85 0.4225
2015-05-13 2015-03-31 13F ABBVIE COM 00287Y109 1,399,233 206,167 17.28 81,911 4.91 0.3376
2015-02-13 2014-12-31 13F ABBVIE COM 00287Y109 1,193,066 614,329 106.15 78,074 133.56 0.3132
2014-11-13 2014-09-30 13F ABBVIE COM 00287Y109 578,737 -41,388 -6.67 33,428 -4.49 0.1429
2014-08-13 2014-06-30 13F ABBVIE COM 00287Y109 620,125 96,816 18.50 35,000 30.12 0.1456
2014-05-13 2014-03-31 13F ABBVIE COM 00287Y109 523,309 -117,883 -18.38 26,898 -20.57 0.1170
2014-02-13 2013-12-31 13F ABBVIE COM 00287Y109 641,192 36,411 6.02 33,862 25.18 0.1516
2013-11-13 2013-09-30 13F ABBVIE COM 00287Y109 604,781 284,505 88.83 27,051 104.31 0.1332
2013-08-12 2013-06-30 13F ABBVIE COM 00287Y109 320,276 320,276 13,240 0.0703
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.